Robyn Jane Macfarlane
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- MicroRNA in disease regulation 2
- Cancer-related molecular mechanisms research 2
- Cancer Genomics and Diagnostics 1
-
- Renal cell carcinoma treatment 2
- Prostate Cancer Treatment and Research 2
- Co-authors
- Kim N. Chi (2 shared papers)Lisa M. Butler (1 shared paper)Scott L. Townley (1 shared paper)Krisna Murti (1 shared paper)Cheryl D. Helgason (1 shared paper)Joanna L. Gillis (1 shared paper)Wayne D. Tilley (1 shared paper)Francesco Crea (1 shared paper)
- Journals
- Otolaryngology (1 paper)Biomarkers in Medicine (1 paper)Clinical Genitourinary Cancer (1 paper)International Journal of Molecular Sciences (1 paper)Annals of Surgical Oncology (1 paper)
- Partner nations
- CanadaUnited StatesAustralia
In The Last Decade
Robyn Jane Macfarlane
14 papers receiving 848 citations
Robyn Jane Macfarlane's Hit Papers
Peers
Comparison fields: 5 of 63
- Cancer Research 285
- Oncology 266
- Surgery 281
- Pulmonary and Respiratory Medicine 167
- Molecular Biology 280
Countries citing papers authored by Robyn Jane Macfarlane
This map shows the geographic impact of Robyn Jane Macfarlane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robyn Jane Macfarlane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robyn Jane Macfarlane more than expected).
Fields of papers citing papers by Robyn Jane Macfarlane
This network shows the impact of papers produced by Robyn Jane Macfarlane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robyn Jane Macfarlane. The network helps show where Robyn Jane Macfarlane may publish in the future.
Co-authors
The 25 scholars most cited alongside Robyn Jane Macfarlane, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial Hit paper breakdown → | 2020 | 400 |
| 2 | 2011 | 161 | |
| 3 | 2013 | 111 | |
| 4 | 2019 | 46 | |
| 5 | 2012 | 38 | |
| 6 | 2010 | 25 | |
| 7 | 2019 | 25 | |
| 8 | 2011 | 24 | |
| 9 | 2010 | 19 | |
| 10 | 2010 | 8 | |
| 11 | 2024 | 5 | |
| 12 | 2012 | 1 | |
| 13 | 2023 | 1 | |
| 14 | 2024 | 1 | |
| 15 | 2025 | 0 |
About Robyn Jane Macfarlane
Robyn Jane Macfarlane is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Oncology, Pathology and Forensic Medicine and Radiology, Nuclear Medicine and Imaging, having authored 15 papers that have together received 865 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (2 papers), Circular RNAs in diseases (2 papers), Cancer-related molecular mechanisms research (2 papers), Renal cell carcinoma treatment (2 papers), Prostate Cancer Treatment and Research (2 papers), Cancer Genomics and Diagnostics (1 paper), Nutrition and Health in Aging (1 paper) and Estrogen and related hormone effects (1 paper). The work is most often cited by research in Cancer Research (285 citations), Oncology (266 citations), Surgery (281 citations), Pulmonary and Respiratory Medicine (167 citations) and Molecular Biology (280 citations). Robyn Jane Macfarlane has collaborated with scholars based in Canada, United States and Australia. Frequent co-authors include Kim N. Chi, Lisa M. Butler, Scott L. Townley, Krisna Murti, Cheryl D. Helgason, Joanna L. Gillis, Wayne D. Tilley, Francesco Crea, Kim Chi and Villis R. Marshall. Their work appears in journals such as Otolaryngology, Biomarkers in Medicine, Clinical Genitourinary Cancer, International Journal of Molecular Sciences and Annals of Surgical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.